Gene therapy in neuromuscular disorders
Abstract Monogenic neuromuscular disorders are potentially treatable through gene therapy. Using viral vectors, a therapeutic transgene aims to restore normal levels of a protein not produced by the defective gene, or to silence a gene whose expression leads to toxic effects. Spinal Muscular Atrophy...
Saved in:
| Main Authors: | Rodrigo Holanda Mendonça, Edmar Zanoteli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2022-08-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700249&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
by: Rodrigo de Holanda Mendonça, et al. -
Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy
by: Li-Kai Tsai, et al.
Published: (2024-07-01) -
A self-reported Brazilian registry of 5q-spinal muscular atrophy: data on natural history, genetic characteristics, and multidisciplinary care
by: Rodrigo Holanda Mendonça, et al.
Published: (2024-12-01) -
Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors
by: Efrain Guzman, et al.
Published: (2025-04-01) -
Congenital contractural arachnodactyly with neurogenic muscular atrophy: case report
by: Rosana Herminia Scola, et al.
Published: (2001-06-01)